About Site
Affordable Medicines Facility - malaria
Board
Business Opportunities
Country Coordinating Mechanisms
Civil Society and the Private Sector
Donate
Donors
Employment
Friends of the Fund
Global Fund Transformation
High Level Independent Review Panel
Innovative Financing
Local Fund Agents
Monitoring and Evaluation
National Strategy Applications
Office of Inspector General
Partnership Forum
Performance Based Funding
Private Sector
Pharmaceutical Procurement and Supply Management
Regional Meetings
Saving Lives: Stories from the Fight
Technical Evaluation and Reference Group
Technical Review Panel
Transitional Funding Mechanism
Since the establishment of the Global Fund in 2002, about 50 countries as well as private foundations, corporations and individuals have pledged and contributed significant resources to support its work. As a means to manage those contributions and to provide sustained and predictable support for the many programs under way in more than 140 countries, the Global Fund uses a periodic replenishment model.
At three-year intervals the Global Fund holds a series of meetings culminating in a pledging conference for all public donors. Replenishment meetings provide a forum for donors to exchange views on the operations and effectiveness of the Global Fund, consider its funding needs and make pledges in respect of their financial contributions for the next three years.
The funds raised from pledging conferences are complemented by additional ad hoc contributions.
The outcome in October 2010 of the Third Replenishment was a strong vote of confidence in the Global Fund, its results, impact and model. The contributions announced constituted the largest-ever financial pledge for the collective, international effort to fight the three pandemics. However, the total fell short of the estimated resources needed to meet demand from developing countries seeking to further scale up their disease programs.
In 2011 the Global Fund will begin an intensified effort to secure funding from new public and private donors and to further develop its work on innovative financing.